Purchase Order 19GE5025P0114
Award Date
9/12/25
Potential Completion Date
11/12/25
Potential Value
$113K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Office of Acquisition Management
Awardee
Bio-Active Company LIMITED
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of Illumina sequencing platforms, including MiSeq and NextSeq systems, to be used for DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. The award has a ceiling value of $223,391.17 and an ultimate completion date of September 7, 2026. Bio-Active Company...
This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
This firm fixed price purchase order was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide Illumina reagents on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The $27,544.10 contract was issued by the U.S. Department of the Army and has a period of performance ending on September 30, 2024. Bio-Active Company LIMITED has a history of delivering genetic sequencing systems, reagents, and testing materials to...
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
The Defense Intelligence Agency awarded a firm fixed price purchase order for $29,116 to Bio-Active Company LIMITED to provide maintenance support for one Illumina MiSeq next generation sequencing system located in Thailand. The order was issued against a blanket purchase agreement held by Bio-Active Company LIMITED to provide sequencing services and instrument sustainment to multiple U.S. agencies in Thailand, including the Department of Defense, Army Medical Command, and Centers for Disease...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...